Dynamics in Post-pandemic Global P2X7 Receptor Antagonists Industry: Supply and Demand, Markets and Prices 2021-2027
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global P2X7 Receptor Antagonists Market Status and Forecast (2016-2027)
- 1.3.2 Global P2X7 Receptor Antagonists Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global P2X7 Receptor Antagonists Supply by Company
- 2.1 Global P2X7 Receptor Antagonists Sales Value by Company
- 2.2 P2X7 Receptor Antagonists Sales Area of Main Manufacturers
- 2.3 Trend of Concentration Rate
3 Global and Regional P2X7 Receptor Antagonists Market Status by Category
- 3.1 P2X7 Receptor Antagonists Category Introduction
- 3.1.1 GSK1482160
- 3.1.2 AZD9056
- 3.1.3 EVT 401
- 3.1.4 JNJ 55308942 & JNJ 54175446
- 3.1.5 AKP-23494954/RQ-00466479
- 3.1.6 Others
- 3.2 Global P2X7 Receptor Antagonists Market by Category
- 3.3 North America: by Category
- 3.4 Europe: by Category
- 3.5 Asia Pacific: by Category
- 3.6 Central & South America: by Category
- 3.7 Middle East & Africa: by Category
4 Global and Regional P2X7 Receptor Antagonists Market Status by End User/Segment
- 4.1 P2X7 Receptor Antagonists Segment by End User/Segment
- 4.1.1 Inflammatory Diseases
- 4.1.2 Central Nervous System Diseases
- 4.1.3 Immune System Disorders
- 4.2 Global P2X7 Receptor Antagonists Market by End User/Segment
- 4.3 North America: by End User/Segment
- 4.4 Europe: by End User/Segment
- 4.5 Asia Pacific: by End User/Segment
- 4.6 Central & South America: by End User/Segment
- 4.7 Middle East & Africa: by End User/Segment
5 Global P2X7 Receptor Antagonists Market Status by Region
- 5.1 Global P2X7 Receptor Antagonists Market by Region
- 5.2 North America P2X7 Receptor Antagonists Market Status
- 5.3 Europe P2X7 Receptor Antagonists Market Status
- 5.4 Asia Pacific P2X7 Receptor Antagonists Market Status
- 5.5 Central & South America P2X7 Receptor Antagonists Market Status
- 5.6 Middle East & Africa P2X7 Receptor Antagonists Market Status
6 North America P2X7 Receptor Antagonists Market Status
- 6.1 North America P2X7 Receptor Antagonists Market by Country
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe P2X7 Receptor Antagonists Market Status
- 7.1 Europe P2X7 Receptor Antagonists Market by Country
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific P2X7 Receptor Antagonists Market Status
- 8.1 Asia Pacific P2X7 Receptor Antagonists Market by Country
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America P2X7 Receptor Antagonists Market Status
- 9.1 Central & South America P2X7 Receptor Antagonists Market by Country
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa P2X7 Receptor Antagonists Market Status
- 10.1 Middle East & Africa P2X7 Receptor Antagonists Market by Country
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Major Downstream Customers Analysis
- 11.1 Customer One Analysis
- 11.2 Customer Two Analysis
- 11.3 Customer Three Analysis
- 11.4 Customer Four Analysis
12 Global P2X7 Receptor Antagonists Market Forecast by Category and by End User/Segment
- 12.1 Global P2X7 Receptor Antagonists Sales Value Forecast (2022-2027)
- 12.2 Global P2X7 Receptor Antagonists Forecast by Category
- 12.3 Global P2X7 Receptor Antagonists Forecast by End User/Segment
13 Global P2X7 Receptor Antagonists Market Forecast by Region/Country
- 13.1 Global P2X7 Receptor Antagonists Market Forecast by Region (2022-2027)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 RaQualia Pharma
- 14.1.1 Company Information
- 14.1.2 P2X7 Receptor Antagonists Product Introduction
- 14.1.3 RaQualia Pharma P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.1.4 SWOT Analysis
- 14.2 Pfizer
- 14.2.1 Company Information
- 14.2.2 P2X7 Receptor Antagonists Product Introduction
- 14.2.3 Pfizer P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.2.4 SWOT Analysis
- 14.3 Janssen
- 14.3.1 Company Information
- 14.3.2 P2X7 Receptor Antagonists Product Introduction
- 14.3.3 Janssen P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.3.4 SWOT Analysis
- 14.4 GlaxoSmithKline
- 14.4.1 Company Information
- 14.4.2 P2X7 Receptor Antagonists Product Introduction
- 14.4.3 GlaxoSmithKline P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.4.4 SWOT Analysis
- 14.5 Evotec
- 14.5.1 Company Information
- 14.5.2 P2X7 Receptor Antagonists Product Introduction
- 14.5.3 Evotec P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.5.4 SWOT Analysis
- 14.6 AstraZeneca
- 14.6.1 Company Information
- 14.6.2 P2X7 Receptor Antagonists Product Introduction
- 14.6.3 AstraZeneca P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.6.4 SWOT Analysis
- 14.7 Asahi Kasei Pharma
- 14.7.1 Company Information
- 14.7.2 P2X7 Receptor Antagonists Product Introduction
- 14.7.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Sales Value, Gross Margin and Global Share (2019-2021)
- 14.7.4 SWOT Analysis
...
15 Conclusion
16 Methodology
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global P2X7 Receptor Antagonists market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global P2X7 Receptor Antagonists market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Segmented by End User/Segment
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
RaQualia Pharma
Pfizer
Janssen
GlaxoSmithKline
Evotec
AstraZeneca
Asahi Kasei Pharma